• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Cara Therapeutics Inc. (CARA)

    -NasdaqGM
    9.78 Up 0.02(0.20%) Dec 24, 12:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 1,125   960   178   973  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,125   960   178   973  
    Operating Expenses
    Research Development6,208  3,200  2,201  1,978  
    Selling General and Administrative1,520  1,472  1,398  1,100  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (6,603) (3,712) (3,421) (2,105)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes(6,577)(3,656)(3,399)1,660  
    Interest Expense -   -   -  3,756  
    Income Before Tax(6,577)(3,656)(3,399)(2,096)
    Income Tax Expense(32)(11)(16)(3)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(6,545)(3,645)(3,383)(2,093)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (6,545) (3,645) (3,383) (2,093)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (6,545) (3,645) (3,383) (2,984)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.